$1.57 Billion in Sales Expected for LifePoint Health, Inc. (LPNT) This Quarter
Equities analysts forecast that LifePoint Health, Inc. (NASDAQ:LPNT) will post $1.57 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have made estimates for LifePoint Health’s earnings, with the highest sales estimate coming in at $1.65 billion and the lowest estimate coming in at $1.54 billion. LifePoint Health posted sales of $1.61 billion in the same quarter last year, which suggests a negative year-over-year growth rate of 2.5%. The business is expected to announce its next quarterly earnings results on Friday, February 16th.
According to Zacks, analysts expect that LifePoint Health will report full year sales of $1.57 billion for the current fiscal year, with estimates ranging from $6.34 billion to $6.45 billion. For the next year, analysts expect that the company will report sales of $6.48 billion per share, with estimates ranging from $6.32 billion to $6.67 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.80 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The company’s quarterly revenue was down .7% on a year-over-year basis. During the same period in the prior year, the business earned $0.94 EPS.
Several research analysts recently commented on the stock. Robert W. Baird set a $55.00 price target on shares of LifePoint Health and gave the stock a “buy” rating in a research note on Monday, October 30th. Zacks Investment Research raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a research report on Monday, August 21st. ValuEngine raised shares of LifePoint Health from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. SunTrust Banks, Inc. set a $54.00 target price on shares of LifePoint Health and gave the company a “hold” rating in a research report on Tuesday, October 31st. Finally, Leerink Swann reissued an “outperform” rating and set a $58.00 target price (down previously from $74.00) on shares of LifePoint Health in a research report on Tuesday, October 31st. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have assigned a buy rating to the company’s stock. LifePoint Health has a consensus rating of “Hold” and an average price target of $60.23.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/11/12/1-57-billion-in-sales-expected-for-lifepoint-health-inc-lpnt-this-quarter.html.
A number of hedge funds have recently added to or reduced their stakes in the stock. Teacher Retirement System of Texas boosted its stake in LifePoint Health by 0.3% in the 2nd quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock worth $216,000 after purchasing an additional 9 shares in the last quarter. US Bancorp DE boosted its stake in LifePoint Health by 0.8% in the 2nd quarter. US Bancorp DE now owns 1,947 shares of the company’s stock worth $130,000 after purchasing an additional 16 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in LifePoint Health by 1.0% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,891 shares of the company’s stock worth $396,000 after purchasing an additional 56 shares in the last quarter. Meeder Asset Management Inc. boosted its stake in LifePoint Health by 0.6% in the 2nd quarter. Meeder Asset Management Inc. now owns 13,547 shares of the company’s stock worth $909,000 after purchasing an additional 76 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in LifePoint Health by 10.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after purchasing an additional 164 shares in the last quarter. Institutional investors own 99.18% of the company’s stock.
LifePoint Health (NASDAQ:LPNT) traded down $1.12 during mid-day trading on Friday, reaching $44.20. 486,800 shares of the company traded hands, compared to its average volume of 648,043. The stock has a market cap of $1,742.19, a P/E ratio of 11.28, a PEG ratio of 1.15 and a beta of 0.68. LifePoint Health has a 52 week low of $44.10 and a 52 week high of $70.95. The company has a quick ratio of 1.65, a current ratio of 1.85 and a debt-to-equity ratio of 1.24.
LifePoint Health announced that its board has approved a share repurchase program on Friday, October 27th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.